Traceability, a Familiar Friend

Modern digital technologies can build in traceability from development to commercialization to optimize outcomes. As cell and gene therapy makes inroads in the life sciences marketplace, an important existing concept from this space has begun to draw more attention than it had previously: traceability.

Emerson’s Director of Life Sciences Strategy Michalle Adkins and Bob Lenich, business director of Emerson’s industrial software business share their thoughts in this article in Pharma Manufacturing magazine on traceability to ensure product efficacy.
 

Latest News

Emerson Announces Support to Educational Programs at the Defence Academy of the United Kingdom

Automation leader provides NI technologies and expertise to educate graduate students on complex test systems.

Emerson’s New Ovation 4.0 to Deliver Software-Defined, AI-Ready Automation Platform for Power and...

New automation architecture accelerates plant modernization with a more flexible and user-centric approach

Emerson Schedules Third Quarter 2024 Earnings Release and Conference Call

Emerson (NYSE: EMR) will report its third quarter results prior to market open on Wednesday, August 7, 2024. Emerson senior management will...
Please enable JavaScript to use this website.